医薬品添加剤市場：タイプ、製剤、機能、エンドユーザー別-2025-2030年の世界予測

医薬品添加剤市場は、2023年に86億2,000万米ドルと評価され、2024年には92億2,000万米ドル、CAGR 7.62%で成長し、2030年には144億2,000万米ドルに達すると予測されています。

医薬品賦形剤市場は、技術革新、法規制遵守、コスト効率に優れた製造の間の鋭敏なバランスを反映し、ダイナミックで多面的なエコシステムへと発展してきました。今日の競合情勢において、賦形剤は単なる添加物ではなく、医薬製剤の有効性、安定性、総合的な品質に影響を与える不可欠な薬剤です。過去10年間で、材料科学の進歩、有効医薬品成分（API）の相互作用の深い理解、オーダーメイドのドラッグデリバリーシステムに対する安定した需要が、賦形剤の分野での力強い成長と多様化に拍車をかけてきました。

メーカーも調査も、賦形剤の伝統的な役割を超えて、洗練されたプロセスや品質基準に傾注しています。この開発は、技術の進歩、厳格な標準化プロトコル、そして持続可能性の重視の高まりが交差して生まれたものです。市場の進化に伴い、企業は現在、技術革新と厳格な規制管理への適合のバランスを取り、最終製品の安全性と有効性の両方を確保することが課題となっています。このイントロダクションでは、医薬品賦形剤業界の現状を定義している動向、セグメンテーション戦略、地域発展、主な企業のハイライトを包括的に深堀りします。

医薬品添加剤市場の変革

医薬品賦形剤市場は、業界のダイナミクスを再構築し、ベストプラクティスを再定義する変革期を迎えています。バイオテクノロジー研究の急速な進展と患者中心の要求の進化が相まって、賦形剤が本来の目的を超えて複数の機能を果たすことが期待される環境に拍車をかけています。患者中心の製剤への注目の高まりにより、より優れたバイオアベイラビリティ、放出制御特性、副作用の最小化を実現する賦形剤へのニーズが高まっています。

製剤科学における技術的な飛躍的進歩により、メーカーは従来の賦形剤と新規材料をブレンドすることが可能になり、多様な治療領域でより適応性の高い製品を生み出しています。さらに、規制環境も厳しくなっており、世界中の規制機関が品質と安全性のベンチマークを厳格に実施しているため、賦形剤の選定は開発プロセスの重要な要素となっています。より高い基準への要求は、メーカーに継続的な技術革新と研究開発への投資を強います。

市場関係者はまた、国境を越えたパートナーシップや戦略的提携によって知識交換が促進され、サプライチェーンが強化されるという、世界化による破壊的なシフトも経験しています。こうした動向を背景に、市場の情勢は、新たな機会を活用するための迅速な対応、戦略的パートナーシップ、機敏な意思決定プロセスが求められるペースで進化しています。

市場セグメンテーションの洞察が市場の変化を促進

医薬品添加剤分野の市場セグメンテーションは、多様な製品群とその用途を詳細に概観するものです。タイプに基づくセグメンテーションでは、無機と有機のカテゴリーが区別されます。無機賦形剤は、炭酸カルシウム、リン酸カルシウム、硫酸カルシウム、ハルライト、金属酸化物などの種類に分類され、それぞれが特定の製剤ニーズに対応する独自の特性を有しています。逆に、有機のカテゴリーは、炭水化物、オレオケミカル、石油化学、タンパク質に分けられ、天然由来と合成工学的材料の両方の重要性を示しています。炭水化物では、結合と安定性において重要な役割を果たすセルロース、デンプン、糖類が特に精査され、油脂化学物質では脂肪アルコール、グリセリン、ミネラルステアリン酸塩が検討され、乳化安定性と潤滑性における多面的な役割が強調されています。さらに、石油化学製品のカテゴリーでは、アクリルポリマー、グリコール、ミネラル炭化水素、ポビドンなどの要素が、製品の性能を高める独自の能力について評価されます。グリコールはもうひとつの明確なサブセグメントであり、ブチレングリコール、ジエチレングリコール、エチレングリコール、ヘキシレングリコール、マクロゴール、マイクログリコール、プロピレングリコールについて綿密に分析され、製剤選択の指針となる細かな区別が示されています。

製品タイプだけでなく、製剤に基づくセグメンテーションは、経口剤、非経口剤、局所剤のレンズを通して市場分析をさらに細分化します。経口製剤はハードゼラチンカプセル、液体製剤、ソフトゼラチンカプセル、錠剤に細分化され、それぞれ送達効率と患者のコンプライアンスに基づいて最終用途を区別しています。機能性セグメントでは、賦形剤を結合剤、コーティング剤、着色剤、崩壊剤、乳化剤、充填剤および希釈剤、香味剤および甘味剤、滑沢剤および滑沢剤、保存剤、懸濁剤および粘稠剤に分類することで、さらに深みを増しています。この分類は、さまざまな機能性が製剤の効率と最終製品の性能をどのように高めるかを理解するのに役立ちます。最後に、バイオ医薬品会社、受託製造機関、製薬会社、研究所など、エンドユーザーに基づくセグメンテーションは、誰が需要を牽引し、最終的に製品設計、品質管理対策、市場展開戦略に影響を与えているかについての貴重な洞察を提供します。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でがんやその他の慢性疾患、感染症の発生率が上昇している
    • 医薬品業界の成長とジェネリック医薬品および希少疾病用医薬品の大きな需要
    • 多機能賦形剤の製造に重点を置く
  • 抑制要因
    • 高度な賦形剤の製造に伴う高コスト
  • 機会
    • 賦形剤ナノテクノロジーの技術的進歩
    • 多様な特性を持つ賦形剤の継続的な研究開発（バイオベース）
  • 課題
    • 規制の厳格化と添加剤の適合性に関する問題の増加
• 市場セグメンテーション分析
  • タイプ：経口固形製剤における有機添加剤の利用増加
  • 配合：飲み込みやすさを考慮したゼラチンベースのシェルが人気上昇中
  • 機能：錠剤処方における結合剤の利用を拡大し、物理的および化学的保護を提供する
  • エンドユーザー：バイオ医薬品企業における新規ドラッグデリバリーシステムをサポートする添加剤の需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 医薬品添加剤市場：タイプ別

• 無機
  • 炭酸カルシウム
  • リン酸カルシウム
  • 硫酸カルシウム
  • 岩塩
  • 金属酸化物
• オーガニック
  • 炭水化物
    • セルロース
    • スターチ
    • 糖類
  • 油脂化学品
    • 脂肪アルコール
    • グリセリン
    • ミネラルステアレート
  • 石油化学製品
    • アクリルポリマー
    • グリコール
    • ブチレングリコール
    • ジエチレングリコール
    • エチレングリコール
    • ヘキシレングリコール
    • マクロゴール
    • マイクログリコール
    • プロピレングリコール
    • 鉱物炭化水素
    • ポビドン
  • タンパク質

第7章 医薬品添加剤市場処方別

• 経口製剤
  • ハードゼラチンカプセル
  • 液体製剤
  • ソフトゼラチンカプセル
  • タブレット
• 非経口製剤
• 局所製剤

第8章 医薬品添加剤市場：機能別

• バインダー
• コーティング剤
• 着色剤
• 崩壊剤
• 乳化剤
• 充填剤と希釈剤
• 香料・甘味料
• 潤滑剤と滑剤
• 防腐剤
• 懸濁剤および増粘剤

第9章 医薬品添加剤市場：エンドユーザー別

• バイオ医薬品企業
• 契約製造組織
• 製薬会社
• 調査室

第10章 南北アメリカの医薬品添加剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の医薬品添加剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの医薬品添加剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• ABITEC Corporation
• Actylis
• Archer Daniels Midland Company
• ARMOR PROTEINES S.A.S. by Savencia Group
• Asahi Kasei Corporation
• Ashland Inc.
• BASF SE
• BIOGRUND GmbH
• Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
• Clariant AG
• Colorcon Inc.
• Corel Pharma Chem Private Limited
• Croda International Plc
• Darling Ingredients, Inc.
• DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
• DuPont de Nemours, Inc.
• Evonik Industries AG
• Fuji Chemical Industries Co., Ltd.
• GATTEFOSSE SAS
• Innophos Holdings, Inc. by Iris Parent LLC
• International Flavors & Fragrances Inc.
• JRS PHARMA GmbH+Co. KG
• Kerry Group P.L.C.
• Lipoid GmbH
• Lubrizol Corporation
• L'AIR LIQUIDE S.A.
• Mallinckrodt plc
• MEGGLE GmbH & Co. KG
• Merck KGaA
• Nagase & Co., Ltd.
• Nipon Soda Co., Ltd.
• NOF Corporation
• Omya International AG
• Peter Greven GmbH & Co. KG
• Roquette Freres S.A.
• Shin-Etsu Chemical Co., Ltd.
• Solvay S.A.
• SPI Pharma, Inc.
• Sumitomo Seika Chemicals Company, Limited
• Thermo Fisher Scientific Inc.
• Vanderbilt Minerals LLC

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL EXCIPIENT MARKET MULTI-CURRENCY
• FIGURE 2. PHARMACEUTICAL EXCIPIENT MARKET MULTI-LANGUAGE
• FIGURE 3. PHARMACEUTICAL EXCIPIENT MARKET RESEARCH PROCESS
• FIGURE 4. PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. PHARMACEUTICAL EXCIPIENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. PHARMACEUTICAL EXCIPIENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL EXCIPIENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL EXCIPIENT MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM CARBONATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM PHOSPHATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HALITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY METAL OXIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUGARS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FATTY ALCOHOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCERIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL STEARATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ACRYLIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BUTYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DIETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HEXYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MACROGOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MICROGLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROPYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY MINERAL HYDROCARBONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY POVIDONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY HARD GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SOFT GELATIN CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PARENTERAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TOPICAL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COATING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COLORANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 56. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY EMULSIFYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 57. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FILLERS & DILUENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 58. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FLAVORING AGENTS & SWEETENERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 59. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 60. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 61. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY SUSPENDING & VISCOSITY AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 62. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 64. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 65. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 66. GLOBAL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 69. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 70. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 71. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 72. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 73. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 74. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 75. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 76. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 77. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. AMERICAS PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 81. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 82. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 83. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 84. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 85. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 86. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 87. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 88. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 89. ARGENTINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 92. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 93. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 94. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 95. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 96. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 97. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 98. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 99. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 100. BRAZIL PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 103. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 104. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 105. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 106. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 107. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 108. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 109. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 110. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 111. CANADA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 114. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 116. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 117. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 118. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 119. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 120. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 121. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 122. MEXICO PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 125. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 126. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 127. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 128. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 129. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 130. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 131. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 132. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 133. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. UNITED STATES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 138. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 140. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 142. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 143. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 144. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 145. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. ASIA-PACIFIC PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 147. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 149. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 150. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 151. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 152. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 153. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 154. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 155. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 156. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 157. AUSTRALIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 160. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 161. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 162. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 163. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 164. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 165. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 166. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 167. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 168. CHINA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 171. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 172. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 173. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 174. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 175. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 176. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 177. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 178. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 179. INDIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 182. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 183. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 184. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 185. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 186. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 187. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 188. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 189. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 190. INDONESIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 193. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 194. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 195. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 196. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 197. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 198. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 199. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 200. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 201. JAPAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 203. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 204. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 205. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 206. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 207. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 208. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 209. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 210. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 211. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 212. MALAYSIA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 213. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 215. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 216. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 217. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 218. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 219. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 220. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 221. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 222. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 223. PHILIPPINES PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 224. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 225. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 226. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 227. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 228. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 229. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 230. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 231. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 232. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 233. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 234. SINGAPORE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 248. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 249. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 250. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 251. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 252. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 253. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 254. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 255. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 256. TAIWAN PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 258. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 259. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 260. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 261. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 262. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 263. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 264. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 265. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 266. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 267. THAILAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 268. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 269. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 270. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 271. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 272. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 273. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 274. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 275. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 276. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 277. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 278. VIETNAM PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 279. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 280. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 281. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 282. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 283. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 284. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 285. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 291. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 292. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 293. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 294. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 295. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 296. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 297. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 298. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 299. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 300. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 301. DENMARK PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 302. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 303. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 304. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 305. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 306. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 307. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 308. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 309. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 310. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 311. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 312. EGYPT PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 313. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 314. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 315. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 316. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 317. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 318. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 319. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 320. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 321. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORAL FORMULATIONS, 2018-2030 (USD MILLION)
• TABLE 322. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 323. FINLAND PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 324. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 325. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY INORGANIC, 2018-2030 (USD MILLION)
• TABLE 326. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY ORGANIC, 2018-2030 (USD MILLION)
• TABLE 327. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
• TABLE 328. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY OLEOCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 329. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY PETROCHEMICALS, 2018-2030 (USD MILLION)
• TABLE 330. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY GLYCOLS, 2018-2030 (USD MILLION)
• TABLE 331. FRANCE PHARMACEUTICAL EXCIPIENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
• TABLE 332. FRANCE PHARMACEUTICAL EX

The Pharmaceutical Excipient Market was valued at USD 8.62 billion in 2023 and is projected to grow to USD 9.22 billion in 2024, with a CAGR of 7.62%, reaching USD 14.42 billion by 2030.

The pharmaceutical excipient market has evolved into a dynamic and multifaceted ecosystem, reflecting a keen balance between innovation, regulatory compliance, and cost-effective production. In today's competitive landscape, excipients are not mere additives; they are essential agents that impact the efficacy, stability, and overall quality of pharmaceutical formulations. Over the past decade, advancements in material science, a deeper understanding of active pharmaceutical ingredients (API) interactions, and a steady demand for tailored drug delivery systems have spurred robust growth and diversification within the excipient arena.

Manufacturers and researchers alike are leaning into sophisticated processes and quality benchmarks that push beyond the traditional roles of excipients. This development comes at the intersection of technological progress, rigorous standardization protocols, and an increasing emphasis on sustainability. As the market evolves, companies are now tasked with balancing innovation and conforming to strict regulatory controls, ensuring that the end products are both safe and effective. This introduction sets the stage for a comprehensive deep-dive into the trends, segmentation strategies, regional developments, and key company highlights that are defining the current state of the pharmaceutical excipient industry.

Transformative Shifts in the Pharmaceutical Excipient Landscape

The pharmaceutical excipient market is undergoing transformative shifts that are reshaping industry dynamics and redefining best practices. Rapid advancements in biotechnological research coupled with evolving patient-focused demands have catalyzed an environment where excipients are now expected to perform multiple functions beyond their original purpose. Enhanced focus on patient-centric formulations has driven the need for excipients that offer better bioavailability, controlled release properties, and minimized adverse reactions.

Technological breakthroughs in formulation science are enabling manufacturers to blend traditional excipients with novel materials, yielding products that are more adaptable across diverse therapeutic areas. Furthermore, the regulatory environment has become more stringent; agencies worldwide are rigorously enforcing quality and safety benchmarks that make excipient selection a critical component of the development process. This push for higher standards compels manufacturers to innovate continuously and invest in research and development initiatives.

Market players are also experiencing disruptive shifts driven by globalization, where cross-border partnerships and strategic alliances facilitate knowledge exchange and bolster supply chains. With these trends in mind, the market landscape is evolving at a pace that demands immediate attention, strategic partnerships, and agile decision-making processes to harness emerging opportunities.

Key Segmentation Insights Driving Market Nuances

Market segmentation in the pharmaceutical excipient space provides a granular overview of the diverse product offerings and their multiple applications. The segmentation based on type distinguishes between inorganic and organic categories. Inorganic excipients are analyzed further into varieties such as calcium carbonate, calcium phosphate, calcium sulfate, halites, and metal oxides, each with its own set of unique properties that cater to specific formulation needs. Conversely, the organic category is divided into carbohydrates, oleochemicals, petrochemicals, and proteins, demonstrating the importance of both naturally derived and synthetically engineered materials. Carbohydrates are particularly scrutinized in terms of cellulose, starch, and sugars, which play critical roles in binding and stability, while oleochemicals are examined via fatty alcohols, glycerin, and mineral stearates to highlight their multifaceted roles in emulsion stability and lubricity. Additionally, within the petrochemicals category, factors such as acrylic polymers, glycols, mineral hydrocarbons, and povidones are assessed for their unique capabilities in enhancing product performance. Glycols, another distinct sub-segment, are meticulously analyzed across butylene glycol, diethylene glycol, ethylene glycol, hexylene glycol, macrogol, microglycol, and propylene glycol, illustrating the fine distinctions that guide formulation choices.

Beyond product type, segmentation based on formulation further refines market analysis through the lens of oral, parenteral, and topical formulations. Oral formulations are sub-divided into hard gelatin capsules, liquid formulations, soft gelatin capsules, and tablets, each differentiating the end-use based on delivery efficiency and patient compliance. Functional segmentation adds an extra layer of depth by classifying excipients as binders, coating agents, colorants, disintegrants, emulsifying agents, fillers and diluents, flavoring agents and sweeteners, lubricants and glidants, preservatives, and suspending and viscosity agents. This categorization helps understand how different functionalities drive formulation efficiency and final product performance. Finally, segmentation based on end-user-covering biopharmaceutical companies, contract manufacturing organizations, pharmaceutical companies, and research laboratories-provides valuable insights into who is driving demand, ultimately influencing product design, quality control measures, and market deployment strategies.

Based on Type, market is studied across Inorganic and Organic. The Inorganic is further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic is further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Butylene Glycol, Diethylene Glycol, Ethylene Glycol, Hexylene Glycol, Macrogol, Microglycol, and Propylene Glycol.

Based on Formulation, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Hard Gelatin Capsules, Liquid Formulations, Soft Gelatin Capsules, and Tablets.

Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.

Based on End-User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Laboratories.

Key Regional Insights Shaping Market Growth

Regional dynamics play a significant role in shaping the trends and growth drivers of the pharmaceutical excipient market. In the Americas, there is a pronounced focus on innovative drug delivery systems and the enhancement of existing formulations, making it a fertile ground for breakthrough advancements. Meanwhile, the Europe, Middle East & Africa region is characterized by its stringent regulatory framework and emphasis on quality control, which has compelled manufacturers to adopt state-of-the-art production and quality assurance practices. In Asia-Pacific, rapid industrialization combined with an expanding healthcare infrastructure creates a vibrant market fueled by both domestic and international investments.

Each of these regions presents unique challenges and opportunities. For instance, while the Americas benefit from a robust network of research institutions that continuously drive innovation, the Europe, Middle East & Africa segment highlights a commitment to meeting both consumer safety and regulatory standards. Asia-Pacific, on the other hand, is positioned as a crucial hub for scaling production and enabling cost efficiencies. This regional analysis underscores the importance of tailored strategies for each geographical area, ensuring that market participants can effectively align their offerings with specific regional demands and regulatory stipulations.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights in the Pharmaceutical Excipient Sphere

The market is dominated by a robust array of key players, each contributing to the innovation and advancement of pharmaceutical excipients. Notable companies such as ABITEC Corporation, Actylis, and Archer Daniels Midland Company leverage deep industry knowledge and extensive research capabilities to drive product enhancements. Industry leaders like ARMOR PROTEINES S.A.S. by Savencia Group and Asahi Kasei Corporation continue to set benchmarks in quality and regulatory compliance, while Ashland Inc. and BASF SE are recognized for their extensive portfolios and diversified market presence.

Further, key entities such as BIOGRUND GmbH, Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG, and Clariant AG have undertaken significant research investments to ensure that their excipients meet the evolving demands of modern drug formulations. Companies including Colorcon Inc., Corel Pharma Chem Private Limited, and Croda International Plc are continuously exploring innovative applications and derivatives to expand their market influence. The competitive landscape is further enriched by Darling Ingredients, Inc., DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V., and DuPont de Nemours, Inc., whose presence underscores the convergence of scientific excellence and market-driven insights. With additional contributions from Evonik Industries AG, Fuji Chemical Industries Co., Ltd., and GATTEFOSSE SAS among others, the market landscape is defined by a blend of legacy expertise and forward-thinking innovation. This powerful collective of market players is pivotal in steering industry trends and forging collaborations that enhance overall market resilience.

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Archer Daniels Midland Company, ARMOR PROTEINES S.A.S. by Savencia Group, Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V., DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc. by Iris Parent LLC, International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L'AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, Roquette Freres S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., Sumitomo Seika Chemicals Company, Limited, Thermo Fisher Scientific Inc., and Vanderbilt Minerals LLC. Actionable Recommendations for Industry Leaders

Industry leaders are advised to invest in R&D and embrace innovative formulation technologies to create multifunctional excipients that cater to evolving therapeutic needs. Continuous monitoring of regulatory changes is crucial, and strategies should incorporate agile quality control processes. Companies must explore strategic partnerships to leverage geographic advantages and cost-effective metabolic innovations, while focusing on sustainability initiatives that align with stringent environmental practices. Emphasizing consumer-centric research and adopting digital solutions for real-time quality analytics can offer competitive advantages in a rapidly evolving marketplace.

Conclusion on Emerging Trends and Long-term Prospects

In conclusion, the pharmaceutical excipient market is poised for significant transformation, driven by innovation, enhanced segmentation strategies, and a rigorous regulatory environment. Market players who successfully integrate research innovation with operational agility will be best positioned to capture emerging opportunities and secure long-term growth. The evolving landscape underscores the importance of strategic alignment, continuous investment, and a keen understanding of regional and functional market drivers.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
    • 5.1.1.2. Growth of the pharmaceuticals industry coupled with significant need for generics & orphan drugs
    • 5.1.1.3. Significant emphasis on the production of multifunctional excipients
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of advanced excipient
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in nanotechnology for excipients
    • 5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
  • 5.1.4. Challenges
    • 5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing utilization of organic excipients in oral solid dose formulations
  • 5.2.2. Formulation: Rising popularity of gelatin-based shell for ease of swallowing
  • 5.2.3. Function: Expanding utilization of binders in tablet formulations to provide physical and chemical protection
  • 5.2.4. End-User: Rising need for excipients in biopharmaceutical companies to support the novel drug delivery systems
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Excipient Market, by Type

• 6.1. Introduction
• 6.2. Inorganic
  • 6.2.1. Calcium Carbonate
  • 6.2.2. Calcium Phosphate
  • 6.2.3. Calcium Sulfate
  • 6.2.4. Halites
  • 6.2.5. Metal Oxides
• 6.3. Organic
  • 6.3.1. Carbohydrates
    • 6.3.1.1. Cellulose
    • 6.3.1.2. Starch
    • 6.3.1.3. Sugars
  • 6.3.2. Oleochemicals
    • 6.3.2.1. Fatty Alcohols
    • 6.3.2.2. Glycerin
    • 6.3.2.3. Mineral Stearates
  • 6.3.3. Petrochemicals
    • 6.3.3.1. Acrylic Polymers
    • 6.3.3.2. Glycols
    • 6.3.3.2.1. Butylene Glycol
    • 6.3.3.2.2. Diethylene Glycol
    • 6.3.3.2.3. Ethylene Glycol
    • 6.3.3.2.4. Hexylene Glycol
    • 6.3.3.2.5. Macrogol
    • 6.3.3.2.6. Microglycol
    • 6.3.3.2.7. Propylene Glycol
    • 6.3.3.3. Mineral Hydrocarbons
    • 6.3.3.4. Povidones
  • 6.3.4. Proteins

7. Pharmaceutical Excipient Market, by Formulation

• 7.1. Introduction
• 7.2. Oral Formulations
  • 7.2.1. Hard Gelatin Capsules
  • 7.2.2. Liquid Formulations
  • 7.2.3. Soft Gelatin Capsules
  • 7.2.4. Tablets
• 7.3. Parenteral Formulations
• 7.4. Topical Formulations

8. Pharmaceutical Excipient Market, by Function

• 8.1. Introduction
• 8.2. Binders
• 8.3. Coating Agents
• 8.4. Colorants
• 8.5. Disintegrants
• 8.6. Emulsifying Agents
• 8.7. Fillers & Diluents
• 8.8. Flavoring Agents & Sweeteners
• 8.9. Lubricants & Glidants
• 8.10. Preservatives
• 8.11. Suspending & Viscosity Agents

9. Pharmaceutical Excipient Market, by End-User

• 9.1. Introduction
• 9.2. Biopharmaceutical Companies
• 9.3. Contract Manufacturing Organizations
• 9.4. Pharmaceutical Companies
• 9.5. Research Laboratories

10. Americas Pharmaceutical Excipient Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Pharmaceutical Excipient Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Excipient Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. GELITA launches endotoxin-controlled excipients portfolio with VACCIPRO and MEDELLAPRO to drive biocompatible innovations
  • 13.3.2. Nucleus Biologics secures EXCiPACT and ISO 9001 certifications to guarantee premium GMP-quality cell culture media and reagents
  • 13.3.3. Nagase Viita to launch SUCROSE SG as an eco-friendly, injectable-grade stabilizer to enhance the stability of biopharmaceuticals
  • 13.3.4. Clariant revolutionizes pharmaceuticals with the launch of high-purity excipients
  • 13.3.5. Shin-Etsu SE Tylose and LBB Specialties forms strategic distribution partnership for cellulose excipients in North and Central America
  • 13.3.6. Evonik's new spray drying facility enhances global supply and sustainability of oral excipients
  • 13.3.7. Roquette's strategic acquisition of IFF Pharma Solutions to bolster global influence in drug delivery solutions and excipients market
  • 13.3.8. Shin-Etsu Chemical to invest JPY 10 billion in expanding global reach of pharmaceutical excipient production
  • 13.3.9. Asahi Kasei enhances pharmaceutical safety with low-nitrite Ceolus MCC excipient and expanded production
  • 13.3.10. Roquette Introduces New Advancement in Moisture Protection
  • 13.3.11. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
  • 13.3.12. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
  • 13.3.13. Lubrizol's Apisolex excipient empowers Welton Pharma to tackle cancer drug solubility challenges
  • 13.3.14. Ingredion leverages strategic acquisitions to strengthen its global pharmaceutical excipient portfolio and enhance offering diversity
  • 13.3.15. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
  • 13.3.16. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
  • 13.3.17. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
  • 13.3.18. Lubrizol Launches Apisolex Technology
  • 13.3.19. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
  • 13.3.20. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. Thermo Fisher Scientific Inc.
  • 13.4.2. Archer Daniels Midland Company
  • 13.4.3. Clariant AG
  • 13.4.4. BASF SE

Companies Mentioned

• 1. ABITEC Corporation
• 2. Actylis
• 3. Archer Daniels Midland Company
• 4. ARMOR PROTEINES S.A.S. by Savencia Group
• 5. Asahi Kasei Corporation
• 6. Ashland Inc.
• 7. BASF SE
• 8. BIOGRUND GmbH
• 9. Chemische Fabrik Budenheim KG by Geschwister Oetker Beteiligungen KG
• 10. Clariant AG
• 11. Colorcon Inc.
• 12. Corel Pharma Chem Private Limited
• 13. Croda International Plc
• 14. Darling Ingredients, Inc.
• 15. DFE Pharma GmbH & Co KG by Royal FrieslandCampina N.V.
• 16. DuPont de Nemours, Inc.
• 17. Evonik Industries AG
• 18. Fuji Chemical Industries Co., Ltd.
• 19. GATTEFOSSE SAS
• 20. Innophos Holdings, Inc. by Iris Parent LLC
• 21. International Flavors & Fragrances Inc.
• 22. JRS PHARMA GmbH + Co. KG
• 23. Kerry Group P.L.C.
• 24. Lipoid GmbH
• 25. Lubrizol Corporation
• 26. L'AIR LIQUIDE S.A.
• 27. Mallinckrodt plc
• 28. MEGGLE GmbH & Co. KG
• 29. Merck KGaA
• 30. Nagase & Co., Ltd.
• 31. Nipon Soda Co., Ltd.
• 32. NOF Corporation
• 33. Omya International AG
• 34. Peter Greven GmbH & Co. KG
• 35. Roquette Freres S.A.
• 36. Shin-Etsu Chemical Co., Ltd.
• 37. Solvay S.A.
• 38. SPI Pharma, Inc.
• 39. Sumitomo Seika Chemicals Company, Limited
• 40. Thermo Fisher Scientific Inc.
• 41. Vanderbilt Minerals LLC